The United States will limit Covid-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine makers to run fresh clinical trials before offering shots ...

Amidst rising COVID-19 cases in Asia, Yale University researchers have discovered that nasal vaccine boosters offer a safer ...

Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the general public.

World Health Organization member countries on Tuesday approved an agreement to better prevent, prepare for and respond to ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift ...

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal guidelines announced Tuesday.

Dr. Susan Girois hosted the conversation discussing several topics relating to vaccines, including how they are developed and tested.

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...